Hughes, Timothy P. http://orcid.org/0000-0002-0910-3730
Clementino, Nelma Cristina D.
Fominykh, Mikhail http://orcid.org/0000-0001-6552-8023
Lipton, Jeffrey H.
Turkina, Anna G. http://orcid.org/0000-0001-9947-2371
Moiraghi, Elena Beatriz
Nicolini, Franck E.
Takahashi, Naoto http://orcid.org/0000-0002-6758-3787
Sacha, Tomasz http://orcid.org/0000-0002-7207-6595
Kim, Dong-Wook http://orcid.org/0000-0003-3967-4267
Fellague-Chebra, Rafik
Tiwari, Ranjan
Bouard, Catherine http://orcid.org/0000-0002-2856-660X
Mahon, Francois-Xavier
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
Article History
Received: 17 February 2021
Revised: 13 April 2021
Accepted: 23 April 2021
First Online: 12 May 2021
Compliance with ethical standards
:
: TPH has received honoraria and research funding from and is a member of a board of directors or advisory committee at Bristol-Myers Squibb and Novartis. NDC has received financial support for congresses from EMS. MF has received honoraria from and is a member of a speakers bureau for BMS, Novartis and Pfizer. JHL has received research funding from and provided consulting to Ariad, Bristol-Myers Squibb, Novartis and Pfizer. AGT has received honoraria from Bristol-Myers Squibb, Novartis, and Pfizer. BM is a member of a speakers bureau for Bristol-Myers Squibb and Novartis. FEN has received honoraria and research funding from Incyte Biosciences and Novartis, and provided consultancy to Analysis Group Inc. and Sun Pharma. NT has received honoraria from Bristol-Myers Squibb, Novartis Pharma KK and Pfizer Japan Inc., and research funding from Novartis Pharma KK and Pfizer Japan Inc. TS has provided consultancy to and received honoraria and research funding from Bristol-Myers Squibb, Incyte, Novartis and Pfizer, and provided consultancy to and received honoraria from Adamed. DWK has received honoraria and research funding from Bristol-Myers Squibb, ILYANG, Novartis and Pfizer, is a member of a speakers bureau for Bristol-Myers Squibb, Novartis and Pfizer, is a member of a board of directors or advisory committee at Bristol-Myers Squibb and Pfizer, and has provided consultancy for ILYANG and Novartis. RFC is employed by, is an equity holder in and has received research funding from Novartis. RT and CB are employed by Novartis. FXM h0as received honoraria from ARIAD, Bristol-Myers Squibb, Novartis and Pfizer, and has received research funding from Novartis. This study was sponsored and funded by Novartis Pharmaceuticals.